| Date | Title | Description |
| 12.11.2012 | FDA-approved patient-monitoring device that can track oxygen levels in the blood raises $15M | The Israeli company, which has U.S. headquarters in Waltham, Massachusetts, developed the device to monitor patients’ vital signs. It also tracks movement to prevent falls, and bed sores that can make the patient vulnerable to hospital-acqu... |
| 23.05.2011 | Building the Israel-Ohio medical connection: Bridge Investment Fund | Two other portfolio companies — Navotek and Medic Vision — haven’t made decisions on their U.S. expansion plans.
The $10 million fund is co-managed by Michael Goldberg, who handles U.S. operations out of Cleveland and Tel Aviv-based Avshalo... |
| 18.05.2011 | Israeli medical device firm IceCure picks Cleveland for U.S. headquarters | “The unique infrastructure for growing biomedical companies, the support we received from many organizations, and the progressive healthcare environment that includes world-class institutions such as the Cleveland Clinic and University Hosp... |
| 28.02.2011 | Cleveland-backed Israeli device firm gets FDA clearance | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 28.02.2011 | Navotek wins FDA clearance for radiation therapy monitor | Israeli company Navotek Medical Ltd., which is backed by a Cleveland-based venture firm, received U.S. regulatory clearance for its radiation therapy monitoring system.
Navotek’s RealEye system obtained 510(k) clearance from the Food & ... |
| 08.02.2011 | Cleveland-funded Israeli biomedical company raises $10M in IPO | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| 20.10.2010 | EarlySense raises $7M for patient monitoring system | Among other uses, the device helps nurses and aides keep a better handle on turning patients in their beds, which prevents pressure ulcers. Clinical evaluations showed EverOn to significantly improve clinical care and lower costs for hospit... |
| 13.10.2010 | Healthcare VC deals tick up during the third quarter | Healthcare-related startups in search of cash have more to be happy about these days as venture capital deals jumped 33 percent during the third quarter, compared to the prior quarter, according to a report by New York-based research firm C... |
| 13.10.2010 | Healthcare venture deals jump 33 percent in third quarter | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermin... |
| 04.10.2010 | EarlySense lands FDA OK for patient data central display | Israeli medical device company EarlySense Ltd. announced today that its EverOn Central Display Station — which accompanies its EverOn Touch patient monitoring system — was cleared the Food & Drug Administration.
The 510(k) clearance cov... |
| 04.10.2010 | EarlySense gets FDA nod for central display of patient data | The EverOn Touch patient-supervision system goes underneath a hospital bed mattress. The device measures a patient” vital signs, such as heart and respiration rates, as well as movements to alert caregivers about his or her medical conditio... |
| 21.06.2010 | EarlySense gets FDA nod for improved patient-monitoring system | EverOn is a patient-supervision system that goes underneath a hospital bed mattress. The device measures patients’ vital signs, such as heart and respiration rates, as well as movements to alert caregivers about their medical condition.
The... |
| 21.06.2010 | EarlySense wins FDA clearance for patient monitoring system | By Mary Vanac
Ramat Gan, Israel-based medical device company EarlySense Ltd., which recently closed a $13 million fund-raising round, received Food & Drug Administration clearance to sell its EverOn Touch patient monitoring system in th... |
| 03.06.2010 | Israel’s EarlySense gets $13M to launch patient monitoring system | At that time, EarlySense said it planned to establish a base of operations in the Cleveland area to develop the next version of its patient-monitoring device. “We have not opened an office yet,” EarlySense CEO Avner Halperin said through a ... |
| 03.06.2010 | Israel’s EarlySense lands $13 million to launch patient monitoring system | By Mary Vanac
Israeli device company EarlySense raised $13 million to launch its EverOn patient monitoring system in the U.S. and Europe.
The Ramat Gan, Israel-based company last year received a grant from the Global Cardiovascular Innovati... |
| 13.10.2009 | Israeli firm EarlySense moving to Cleveland, developing new heart-monitoring application | Blue Ash Therapeutics of Cincinnati, which is developing a drug to treat abnormal heartbeats in conjunction with implantable defibrillators
Cardioception of Cincinnati to develop a treatment to increase the rate of healing after a heart att... |
| 08.06.2009 | An early sense on an Israeli device business that could come to Ohio | Plus, virtually everything that needs to be done to lure EarlySense could be done here. Halperin said the location of its U.S. office would depend on the source of additional funding, new strategic partnerships and proximity to new customer... |
| - | Israeli medical device firm IceCure picks Cleveland for U.S. headquarters | Israeli device company IceCure Medical has chosen Cleveland to be its U.S. headquarters, a move the company’s CEO hinted at in February.
The company plans to open its U.S. headquarters at the Cleveland Clinic-led Global Cardiovascular Innov... |
| - | FDA-approved patient-monitoring device that can track oxygen levels in the blood raises $15M | A medical technology startup has raised fresh capital after securing regulatory approval to expand its patient-monitoring device to monitor oxygen levels in patients following surgery.
EarlySense raised $15 million in a series E financing r... |
| - | EarlySense gets FDA nod for central display of patient data | Israeli medical device company EarlySense Ltd. announced today that its EverOn Central Display Station — which accompanies its EverOn Touch patient monitoring system — has been cleared for marketing in the United States by the Food and Drug... |
| - | Israeli firm EarlySense moving to Cleveland, developing new heart-monitoring application | CLEVELAND, Ohio — Israeli device company EarlySense will launch its product in the United States next year and will establish a base of operations in Greater Cleveland to develop the next version of the device.
EarlySense, which monitors a ... |
| - | Cleveland-funded Israeli biomedical company raises $10M in IPO | An Israeli medical device company backed by a Northeast Ohio venture capital firm has raised more than $10 million in an initial public offering on the Tel Aviv Stock Exchange.
Now the company, IceCure Ltd., is exploring whether to set up i... |
| - | Building the Israel-Ohio medical connection: Bridge Investment Fund | Bridge Investment Fund recently scored its biggest win — in the eyes of job-creation-conscious local investors, at least — when Israel-based portfolio company IceCure decided to establish its U.S. headquarters in Cleveland.
That’s exactly w... |
| - | Israel’s EarlySense gets $13M to launch patient monitoring system | Updated 6:59 p.m.
Israeli device company EarlySense has raised $13 million from investors to launch its EverOn patient monitoring system in the United States and Europe.
The company based in Ramat Gan, Israel last year received a grant from... |
| - | EarlySense raises $7M for patient monitoring system | EarlySense has raised $7 million in investment funding to continue commercializing its patient monitoring system for hospitals and acute care centers, bringing its fundraising for the year to an impressive $20 million.
The company’s EverOn ... |
| - | An early sense on an Israeli device business that could come to Ohio | Last month’s announcement that three more Israeli companies are moving to Ohio is the latest example of how Greater Cleveland is getting more international and using Israel as its focal point. There have been flirtations with Eastern Europ... |
| - | Cleveland-backed Israeli device firm gets FDA clearance | Israeli company Navotek Medical, which is backed by a Cleveland venture firm, has received U.S. regulatory clearance for its radiation therapy monitoring system.
Navotek’s RealEye system obtained 510(k) clearance from the U.S. Food and Drug... |
| - | EarlySense gets FDA nod for improved patient-monitoring system | Updated 12:20 p.m., June 22, 2010.
Israeli medical device company EarlySense Ltd., which recently closed a $13 million fundraising round, has received Food and Drug Administration (FDA) clearance to sell its EverOn Touch patient-monitoring ... |
| - | Healthcare venture deals jump 33 percent in third quarter | Smile, healthcare entrepreneurs.
Health startups in search of cash have more to be happy about because healthcare venture capital deals jumped 33 percent in the third quarter compared to the prior quarter, according to a new report from New... |
